Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05674292 · ClinicalTrials.gov registry record · NA
An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring
A NA study of Circumference Reduction, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT05674292: Completed NA study of Circumference Reduction, sponsored by Erchonia Corporation.
NCT05674292 is a NA study of Circumference Reduction that has completed, run by Erchonia Corporation. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05674292, a NA study of Circumference Reduction, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.
Primary Outcome
Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.
Conditions Studied
Interventions
- DEVICE Erchonia Violet Zerona Z6
Study Locations (2)
Michigan
- Tracey Hishon - Bloomfield Hills
- Jamie Thayer - Marquette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
What the finished NCT05674292 record still lists
NCT05674292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Circumference Reduction appearing as the primary indexed condition, and to 1 intervention - of which Erchonia Violet Zerona Z6 is the first listed.
NCT05674292 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05674292 about?
NCT05674292 is a clinical study titled "An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring". The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.
What is the current status of trial NCT05674292?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-07-11. Estimated completion is 2023-03-28.
What conditions does trial NCT05674292 study?
This clinical trial studies the following conditions: Circumference Reduction.
What interventions are being tested in trial NCT05674292?
The interventions under investigation include: Erchonia Violet Zerona Z6 (DEVICE).
Who is sponsoring clinical trial NCT05674292?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05674292 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05674292's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI